For more on ASPMN® accredited courses, click here.
Opiate Painkiller Dependence Myth Debunked: Painkillers Prescribed After Major Injury Do Not Lead To Long-Term Use
The Joint Commission has approved the following revisions for prepublication for the standards related to pain assessment and management.
Click here for full document.
We had a great Town Hall Meeting on August 22. Click here to download the handouts and here to listen to the webinar.
The Department of Health and Human Services today released their Final Report on Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations.
As you know we provided comments and have participated in public meetings leading up to the release.
You can find the report here.
At President Trump’s direction, the Centers for Medicare & Medicaid Services (CMS) today is issuing an unprecedented array of temporary regulatory waivers and new rules to equip the American healthcare system with maximum flexibility to respond to the 2019 Novel Coronavirus (COVID-19) pandemic. CMS sets and enforces essential quality and safety standards for...[Read More]
ASPMN® has responded to the request from our members to examine ways in which we can begin to address issues of implicit bias and disparities impacting the care of our vulnerable patients with pain. No experience or advanced knowledge is needed to participate in this task force, only an interest and willingness to join your colleagues in this initiative under the leadership of Dr. April Vallerand. For more information or to volunteer for this opportunity to work with a great group of people on an important initiative, please email Maureen Cooney, ASPMN®® President, at mcooneyASPMN®@gmail.com.
It's ASPMN®'s 30th Anniversary! Help us to celebrate by making a donation of $30 or more - the donation will assist ASPMN® in developing educational materials so they remain accessible and affordable.
ASPMN recognizes the systemic racism that has affected not only our Black and Brown patients but also our healthcare professional colleagues. Our collective pain and suffering have reached new levels as our nation struggles with a crisis of conscience that has emerged on top of the COVID-19 health crisis.
As nurses - and more specifically as people who care - we advocate for those who are suffering. For physical pain, that means providing safe and effective pain management. For the emotional and societal pain we now face, however, the solutions will be more difficult.
We call on our peers to help us in a search for answers and invite you to join a forum to share what you are seeing, how you are feeling, and how we, as a profession, can take effective action.
We are starting that conversation today by asking each of you to share what's going on for you. What level of pain and grief are you feeling? How are you coping? What small or large things are you doing to help manage the pain for ALL your patients? And most of all, how can we help?
Please reach out to us at
We are seeking your nominations of candidates to stand for election for the 2021-23 ASPMN® Board of Directors. Member engagement is critical to the success of ASPMN®, and the Board relies upon your recommendations for strong candidates. Even if you are new to the association, please consider colleagues you know. We are always looking for the next generation to lead our organization.
The positions that will be elected by the membership in 2021 are:
Positions begin terms in October 2021. Review the position criteria carefully to acquaint yourself with each position. This information will assist you in recommending for nomination the best candidate for the office. It is our goal to offer more than one candidate for each office; however, this is dependent upon receiving a sufficient number of nominations for each office from the membership. You may recommend yourself or another ASPMN® member for nomination by completing the electronic submission form. All recommendations MUST BE RECEIVED BY May 30, 2021 to be considered for the slate of candidates. Please have the following information ready when submitting the nomination:
Recommendations should be electronically submitted to ASPMN® 's Executive Office here.
SAMHSA has published a series of Advisories based on existing Treatment Improvement Protocols (TIPs) and Technical Assistance Publications(TAPs). These Advisories summarize updated guidance and recommendations on topics in the substance use disorder (SUD) treatment field. The new Advisories include:
Application Deadline December 31, 2021
The Advanced Practice (AP) Portfolio Program is a mechanism for demonstrating advanced level knowledge and competency in the practice of pain management nursing evidenced by completion of:
ASPMN® began the Advanced Practice Portfolio Recognition in 2014. Qualified nurses may be recognized as having achieved Advanced Practice Competency in Pain Management Nursing by fulfilling the activity requirements of the Advanced Practice (AP) portfolio. Advanced Practice Registered Nurses (NP, CNS, CRN, and CNM) that carry a current pain management nursing certification can apply for AP recognition via portfolio. Successful applicants earn the credential AP-PMN and can use the distinction to highlight their competency of this focused practice designation.There are two application cycles per year:
Cycle 1 - Applications received by May 31
Cycle 2 - Applications received by December 31
Successful applicants will be recognized at ASPMN®'s 2022 National Conference during the awards ceremony.
For more information and to download the application, click here.
"Positioning Effects for Procedural Pain Relief in NICU: Systematic Review"Anilsa Suraya Pedro Gaspar Francisco; Dayane Montemezzo, PhD; Simone Nascimento dos Santos Ribeiro, PhD; Bruna Frata, MD; Natália Alves Menegol; Rodrigo Okubo, PhD; Anelise Sonza, PhD; Luciana Sayuri Sanada, PhD
Last week, Representatives David B. McKinley, P.E. (R-WV-01) and Lori Trahan (D-MA-03) reintroduced the Medication Access and Training Expansion (MATE) Act, which would require all DEA controlled substance prescribers, who are not already addiction specialists, to dedicate at least eight hours of training on treating patients with opioid or substance use disorder (SUD). The bill would also require certain professional schools to incorporate addiction medicine education to their curricula and would authorize the federal government to provide grants to schools to develop trainings and curricula for prescribers on how to identify and treat SUDs. In a press release, Representative McKinley said, "Ensuring that physicians and other prescribers have the tools and knowledge available to them to identify and create an effective treatment course for patients with substance use disorder is critical to getting the opioid crisis under control."
Representative Trahan added, "Congress has an obligation to undertake a holistic approach to ending the addiction crisis that has taken far too many lives already. That can't happen without understanding addiction's root causes and the stigma associated with seeking out help. The MATE Act will ensure that medical professionals across the nation have standardized training that not only ensures a strong understanding of addiction, but also gives them the tools necessary to identify, treat, and manage patients with substance use disorders." This bill was previously introduced in the House during the 116th Congress.
Articles & Resources
Representative David B. McKinley, P.E. – McKinley Introduces Bipartisan Legislation to Combat Prescription Opioid Abuse
Representative Lori Trahan – Trahan Leads Reintroduction of Bipartisan Legislation to Tackle Root Causes of Addiction Crisis
H.R.4974 - MATE Act of 2019
Help us spread the word about getting vaccinated by using one of our new Facebook frames! Log in to your Facebook profile, select "change my profile picture" and then "Add a Frame." Search for our frame using "ASPMN®" and then select one of our three frame options to announce you have been vaccinated. Be sure to use the hashtag #ASPMNLearns and tag ASPMN® on Facebook.
Please remain vigilant and maintain proper safety precautions after vaccination. Stay safe!
The Centers for Disease Control and Prevention (CDC) recently added substance use disorders (SUD), including alcohol, opioid and cocaine use disorders, to their list of underlying medical conditions that can make an adult more likely to get severely ill from the COVID-19 virus. The decision to add SUDs was based on a comprehensive evidence review process, which included analyzing publications, scientific articles, journal pre-prints, and internal CDC data on substance use disorders from December 1, 2019 to January 2021. During a White House press briefing on the COVID-19 response, CDC Director Dr. Rochelle Walensky said, "This update is keeping up with my commitment to lead with science, to have clear information on our website, and to better describe the science underlying these conditions."
CDC – People with Certain Medical Conditions
CDC – Scientific Evidence for Conditions that Increase Risk of Severe Illness
The White House - Press Briefing by White House COVID-19 Response Team and Public Health Officials
Last week, the Office of National Drug Control Policy (ONDCP) released a statement by the Biden-Harris Administration outlining their drug policy priorities for year one, which will largely focus on racial equity in drug policy and advancing harm-reduction efforts. According to the statement, the Administration's seven drug policy priorities include expanding access to evidence-based treatment, advancing racial equity in drug policy, enhancing evidence-based harm reduction, supporting evidence-based prevention to reduce substance use in youths, reducing the illicit substances supply, expanding the addiction workforce and recovery-ready workplaces, and expanding access to recovery services. ONDCP also emphasized their commitment to coordination, highlighting that they will work closely with other White House offices, federal agencies, Congress, and State, local, and Tribal governments to meet their year one priorities.
The White House – The Biden-Harris Administration's Statement of Drug Policy Priorities for Year One
ASPMN® is currently accepting poster submissions through May 15. Submit your poster presentation here.
Below are basic instructions that will help you with your submission.
The proposal submission form asks for author contact information, title, brief description of the submission (100 words or less) and an abstract (300 words or less).The conference planning committee is currently accepting clinical, research, and industry posters. No other submission types are being accepted at this time.
Last week, Representatives Annie Kuster (D-NH-02) and Lisa Blunt Rochester (D-DE-AL) introduced the Support, Treatment, and Overdose Prevention of (STOP) Fentanyl Act of 2021, which aims to expand research and education efforts to detect and monitor fentanyl, enhance overdose prevention interventions, expand access to substance use disorder treatment programs, increase public health trainings for law enforcement, and increase synthetic drug surveillance. In a press release, Representative Kuster said, "I'm proud to introduce this legislation to bolster our national response to the opioid epidemic and connect individuals with treatment and recovery programs. We cannot turn our backs on those struggling with substance abuse, and I look forward to working across the aisle on the Bipartisan Addiction and Mental Health Task Force to address this crisis that impacts communities nationwide." Representative Blunt Rochester added, "synthetic opioids, like fentanyl, have had a devastating impact throughout Delaware and across the United States, especially in the wake of the COVID-19 pandemic. Due to the stark rise in overdose fatalities from fentanyl, it is time for Congress to take long-term action to save lives."
Representative Ann McLane Kuster – Fitzgerald, Johnson Introduce SOFA Act to Combat Opioid Epidemic
STOP Fentanyl Act of 2021
Representative Rodney Davis (R-IL) recently reintroduced the Opioid Prescription Verification Act, which would require pharmacists to check IDs when dispensing opioids and enter the information of the person picking up an opioid prescription into the state Prescription Drug Monitoring Program to allow law enforcement to track patterns of abuse. The legislation would also require the Centers for Disease Control and Prevention (CDC) to collaborate with other agencies to provide guidance to pharmacists on ID checks and safe dispensing. In a press release, Representative Davis said, "this legislation, inspired by a meeting I had with the Normal Police Department a few years ago, would empower law enforcement to monitor 'pharmacy shopping' and track bad actors who abuse opioid prescriptions. It's common sense that individuals should be required to show ID to pick up opioid prescriptions, which are highly addictive and a contributing factor to the opioid epidemic." This bill was previously introduced in the Senate during the 116th Congress
Rep. Rodney Davis – Davis Re-introduces Opioid Prescription Verification Act to Combat Opioid Epidemic
"The ASPMN® Education Committee is charged with the responsibility to "promote the development of educational materials to foster excellence in pain management."
Currently, we are working with authors to review and update the ASPMN position statements that serve to educate the pain community as to the organization's viewpoints and direction on relevant pain-related topics and encourage best practices. We are leading a bi-monthly Pain Management Nursing Journal Club to enhance knowledge and skills in pain management, facilitate networking, and sustain and encourage membership. Annually, we review presentation materials for the ASPMN conference. We also pursue any other project assigned by the Board of Directors that are related to education.
The Education Committee is composed of two co-Chairs and 17 members with 3 ad hoc members. Our current members are in various areas of acute and chronic pain, inpatient/outpatient settings, and pediatric/adult areas. Our thoughtful and energetic members actively participate to promote the overall goal of the committee to enhance education toward advancing the mission and goals of ASPMN.
Pamela Jean Merriam, dearly loved and most amazing
nurse practitioner, passed to the other side on December 15, 2020. She
stubbornly waited to do so, longer than seemed humanly possible that day, for
completion of one of her wishes. In typical Pamela fashion, she stubbornly
refused to leave this existence until the moment everything was finalized for
her last contribution to the medical field, an organ donation. She is survived
by her sister, two nieces, two great nieces, a great nephew, her godparents, a
panoply of friends and professional colleagues who loved and admired her and
whom she loved with all her heart.
Our friend was also a leader and teacher in her
craft and had an intimidating resume that reads like a novel. Pamela skillfully
created a bridge between her knowledge and her patients, delivering the utmost
care in attending to their needs. She also taught the NP students at UCLA and
USC how to build this bridge in their careers. Her professional career was
beyond reproach and her bedside manner, meshed with her ability to clearly
articulate her extensive medical knowledge, was a breath of fresh air for those
who received or sought her counsel. [Read
Full Obituary Here] The site is interactive, and until approximately May
21, you can post memories and share photos.
Some have asked about appropriate donations in
Pamela's honor. She would appreciate donations to any of the following:
Cetacean Society International
World Wildlife Federation
National Resource Defense Council
National Parks Service
us to celebrate excellence in nursing by recognizing yourself or a colleague
for one of ASPMN®’s annual awards.
These awards are for EVERY
nurse! There are no degree or title requirements. If you’re a nurse doing good
work for patients with pain, we want to hear about it!
Check out the awards and criteria here. Submitting a nomination is easier than ever. The
process for online submission takes about 10 minutes if you have the
candidate’s CV and letter of recommendation available ahead of time. The
deadline for submission is July 19, 2021. Submit a nomination for
yourself or another outstanding nurse today!
On May 19th, the House of Representatives passed the Fairness in Orphan Drug Exclusivity Act, reintroduced by Representatives Madeleine Dean (D-PA-4) and Marc Veasey (D-TX-33), in a vote of 402-23. The current law has been cited as a potential obstacle to competition in the development of opioid use disorder treatments. If enacted, the bill would require manufacturers seeking approval and market exclusivity for a new version of a drug to show that they have no expectation of recouping their research and development costs through U.S. sales. The Fairness in Orphan Drug Exclusivity Act was previously introduced during the 116th Congress and passed unanimously in the House in November 2020. Articles & Resources Representative Madeleine Dean – Rep. Dean's Bipartisan Legislation Passes House — Bill will Allow New Treatments for Opioid Use Disorder H.R.4712 – Fairness in Orphan Drug Exclusivity Act
Two conference scholarships for up to $1,500 each are available for the 2021 National Conference from the Jean Guveyan Education Fund.
Qualifications for Applicants:
Winners will attend the Jean Guveyan reception on Thursday, September 30th to meet Past-Presidents and give an informal three-minute talk on graduate pain management work or pain management practices.
Scholarship is to be used toward recipient's 2021 National Conference expenses, including:
Application Deadline: July 9, 2021
Click Here To Apply!
The selection of two qualifying applicants will be determined by a committee of ASPMN® Past-Presidents.
Award winners will be notified in mid-July.
Last week, the Senate Appropriations Committee held two hearings to discuss the Biden Administration's FY 22 budget proposals for the Health and Human Services (HHS) and the Food and Drug Administration (FDA). On June 9th, HHS Secretary Xavier Becerra served as the sole witness during the Labor, Health and Human Services, Education, and Related Agencies Subcommittee hearing. During his testimony, Secretary Becerra noted the increase in opioid overdose deaths and highlighted that the FY 22 budget would be used to increase access to opioid use disorder medications, expand the behavioral health workforce in underserved areas, and create targeted investments to the Substance Abuse and Mental Health Services Administration. The FY 22 budget proposal includes $11.2 billion for HHS to address the opioid epidemic and includes $3.5 billion for the Substance Abuse Prevention and Treatment Block Grant. In response to a question from Senator Patrick Leahy (D-VT) about opioid alternatives, Secretary Becerra said that HHS' role would be to support state and local partners as they develop solutions to address substance use disorders. On June 10th, FDA Acting Commissioner Dr. Janet Woodcock testified at the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee hearing. Dr. Woodcock noted that the agency would earmark $38 million to advance their goal of ending the opioid crisis and would achieve this goal by developing opioid reversal treatments, digital technologies for opioid use disorder, and improved opioid guidance for clinicians.
Articles & ResourcesSenate Appropriations Committee – Hearing on the President's Fiscal Year 2022 Budget Request for the United States Department of Health and Human ServicesXavier Becerra TestimonyMedPage Today – Senate Hearing on HHS Budget Showcases Divide Among Democrats, RepublicansSenate Appropriations Committee – Hearing on the Fiscal Year 2022 Budget Request for the Food and Drug Administration Janet Woodcock Testimony MedPage Today – FDA's $6.5B Budget Request Targets Opioid Epidemic
Thank you to those who have already submitted their vote. The election will run through July 31.
The 2021 Nomination Committee has brought together an excellent slate of candidates for the 2021 election. ASPMN® members should have received a personalized election ballot link via email on July 1 (only members who have paid 2021 ASPMN® membership fees are eligible to vote). If you have not already voted, please do so! If you did not receive your individual ballot email, please email the ASPMN® Executive Office.